Sort
39,280 grants matching “leukemia”
Rac proteins in hematopoietic cell survival and function
$407,232David A Williams · Boston Children'S Hospital · R01 · FY2014 · DK
Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
$407,206Malathy (mala) Shanmugam · Emory University · R01 · FY2017 · CA
Regulation of CXCR4 by cognate and non-cognate ligands
$407,200Elias Lolis · Yale University · R01 · FY2009 · AI
Metabolic pathways in leukemia
$407,175John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2015 · CA
Regulation of Embryonic Erythropoiesis by BMP Signaling
$407,154Todd R Evans · Weill Medical Coll Of Cornell Univ · R37 · FY2012 · HL
Modulating HSC-niche interactions to understand aging and improve transplantation
$407,141Hiromitsu Nakauchi · Stanford University · R01 · FY2019 · HL
Lnk Regulatory Functions in Hematopoietic Stem Cells
$407,138Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2012 · HL
Congenital cytomegalovirus infection, KIR genotypes, and acute lymphoblastic leukemia
$407,134Logan G Spector · University Of Minnesota · R01 · FY2020 · CA
Molecular Pathogenesis and Therapy of ET and PMF
$407,075Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Project 1 Melnick
$407,046Ari M. Melnick · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · CA
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)
$406,973William L. Carroll · New York University School Of Medicine · R01 · FY2013 · CA
Molecular and functional dissection of the zebrafish hematopoietic stem cell niche
$406,941David Traver · University Of California, San Diego · R01 · FY2024 · DK
Mechanisms of Apoptosis Dysregulation in AML
$406,928John C Reed · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
MPN-inducing mutations as biomarkers of synthetic lethality
$406,919Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2024 · CA
Using natural antibodies to improve vaccines
$406,891John J Iacomini · Tufts Medical Center · R01 · FY2012 · AI
Functional Analysis of the Human Leukemia Gene E2A-PBX1
$406,851Mark P Kamps · University Of California, San Diego · R01 · FY2006 · CA
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations
$406,847Nicholas Pannunzio · University Of California-Irvine · R37 · FY2025 · CA
MOLECULAR STUDIES OF HEMATOPOIETIC STEM CELLS
$406,822Ihor R Lemischka · Princeton University · R37 · FY2006 · DK
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
$406,800Saghi Ghaffari · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK
Define the role of POT1 mutations in genome instability and cancer
$406,771Agnel Sfeir · New York University School Of Medicine · U01 · FY2018 · CA
Unbiased identification of spliceosome vulnerabilities across cancer
$406,727Nathan G. Salomonis · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Modulating HSC-niche interactions to understand aging and improve transplantation
$406,711Hiromitsu Nakauchi · Stanford University · R01 · FY2018 · HL
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
$406,701Hannah Choe · Ohio State University · R01 · FY2023 · CA
Identifying host factors that block engraftment and progression of transmissible cancer as a model of AML
$406,685Michael Jeffrey Metzger · Pacific Northwest Research Institute · R01 · FY2025 · CA
Exploring oncogenic translation programs in cancer
$406,648Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA